How can we help our abuelos and other loved ones who are dealing with Alzheimer's disease? Clinical trials! These are studies with volunteers that help researchers learn more to help slow, manage, and treat Alzheimer’s for current and future family members. But without volunteers for clinical trials, the benefits may miss certain groups. That's why Salud America! is joining the San Antonio Center for Alzheimer’s Disease and Related Dementias (AD/ADRD) Population Aging and Social Studies (CAPAS). CAPAS will unite researchers from UT San Antonio, the Center for Brain Health, the Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and others. Community Impact, a local news agency across Texas, featured the effort in an article and interviewed Dr. Amelie G. ...
Firefighters are at higher risk of cancer than the general population. That is the reason for the new San Antonio Firefighters Cancer Prevention Program. The program aims to better understand and reduce the cancer burden among local firefighters and emergency medical services personnel. It is a partnership of the San Antonio Fire Department, UT Health San Antonio, and Sylvester’s Firefighter Cancer Initiative at the University of Miami. Now the program is featured in an article in San Antonio Medicine, a publication of the Bexar County Medical Society. The article was written by Dr. Rachelle Hamblin, a family medicine physician at Health by Design, the SAFD Retiree Police and Firefighter Clinic; Dr. Amelie G. Ramirez, leader of the Institute for Health Promotion Research at UT ...
Dr. Amelie G. Ramirez, leader of Salud America! and cancer health researcher at the Mays Cancer Center at UT Health San Antonio, has been selected for the Lifetime Achievement Award from the National Hispanic Council on Aging (NHCOA). The award honors individuals who have "demonstrated a significant and lasting impact on improving the lives of older adults, particularly Hispanic older adults," by promoting health and building healthy communities. Ramirez received the award at the 2025 NHCOA Awards Ceremony on Dec. 18, 2025, in Washington, D.C. Watch the livestream of the award ceremony. "I am truly humbled to be selected," Ramirez said. "NHCOA’s work is deeply meaningful, and to be recognized by an organization so dedicated to advancing the well-being and dignity of our ...
The Salud America! program, led by Dr. Amelie G. Ramirez of UT Health San Antonio, has received the National Health Award from the National Association of Medical Spanish (NAMS) and the Medical Organization for Latino Advancement (MOLA). The award was given during the MOLA-NAMS Annual Conference in November 2025 in San Antonio. "I am truly humbled and honored to accept this recognition on behalf of our Salud America! program, and the countless storytellers, community leaders, and cancer survivors who walk with us on this journey toward better health for all people," Ramirez said. Ramirez launched Salud America! in 2007 to create data-driven news report, role model stories, and action opportunities for better health for all. "Thanks to our passionate team and network, we’ve ...
Dr. Amelie G. Ramirez, leader of Salud America! and a cancer health researcher at the Mays Cancer Center at UT Health San Antonio, joined a special episode of The Cancer Letter Podcast in honor of Hispanic Heritage Month to discuss cancer, policy, and communities. In the podcast episode, Dr. Ramirez joined with Dr. Ruben Mesa, executive director of the Atrium Health Wake Forest Baptist Comprehensive Cancer Center, and Dr. Luis Carvajal Carmona, associate vice chancellor and professor in the Department of Biochemistry and Molecular Medicine at University of California, Davis. The trio discuss federal policy impact on cancer, including the non-medical drivers of health, research investment, and AI. It’s really been a mission of mine to really raise the flag on the importance ...
Dr. Amelie G. Ramirez, leader of Salud America! and cancer health researcher at the Mays Cancer Center at UT Health San Antonio, will receive the 2025 Sedgwick Memorial Medal for Distinguished Service in Public Health from the American Public Health Association (APHA). The award recognizes Ramirez's work in public health, which spans more than 30 years, and is a powerful testament to the legacy of the late Dr. Sedgwick. Ramirez and other APHA awards will be honored Monday, Nov. 3, 2026, during APHA’s 2025 Annual Meeting and Expo. "We celebrate the accomplishments and commitment of [Dr. Ramirez and] these outstanding public health leaders," said Dr. Georges Benjamin, APHA leader, in a statement. "Their contributions have helped strengthen the field and provide inspiration as we ...
For seniors and other immunocompromised individuals, the best way to protect against severe effects from COVID-19 is to stay up-to-date with the CDC's vaccine recommendations and available treatments. But antivirals are underused. That's why our friends at CVEEP have resources to help protect against infectious respiratory diseases across the lifespan. CVEEP recently featured Dr. Amelie G. Ramirez, leader of Salud America! and cancer health researcher at the Mays Cancer Center at the University of Texas at San Antonio Health Science Center, in a radio campaign for early treatment. The campaign, in English and Spanish, aired on 899 stations and generated 45.2 million impressions. "Please don't wait. Early treatment [of respiratory illnesses] makes a big difference," ...
What do we know about cancer trends in Latino communities? Find answers in the new episode of the Cancer Health podcast from the Office of Community Outreach & Engagement at Fred Hutch Cancer Center in Seattle. The episode, "Cancer Trends in Latino Communities," features Dr. Amelie G. Ramirez, leader of Salud America! and cancer health researcher at the Mays Cancer Center at the University of Texas at San Antonio Health Science Center, Ysabel Duron from The Latino Cancer Institute, and Gladys Arias from the American Cancer Society Cancer Action Network Washington. Together, they discuss cancer trends impacting communities in Washington, California, and Texas. They cover liver, cervical, pediatric leukemia, and more. Listen online, Apple Podcasts, or other podcast ...
Immune checkpoint inhibitors have been a game-changer in oncology. Tumors often have proteins on them that tell your immune system not to attack. Checkpoint inhibitors, which work by blocking these proteins so your immune system continues to fight the tumor, have provided new options for many people with advanced or metastatic cancer who were left with limited options. Patricia Moreno, Ph.D., lead of Evidence-Based Survivorship Supportive Care at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, points out that these new drugs come with unique side effects that experts still need to understand better.
The National Cancer Institute has awarded Dr. Moreno, a member of Sylvester’s Cancer Control Program, and co-investigators Jose ...
